Showing results 1 to 2 of 2
| Title | Author(s) | Issue Date | |
|---|---|---|---|
An integrated analysis of phase 2,3 SOF and LDV/SOF trials for the treatment of GT6 HCV Infection Proceeding/Conference:Hepatology International | 2016 | ||
Sofosbuvir plus ribavirin for 12 16 or 24 weeks results in sustained virologic response over 97% in genotype 1 and 6 HCV infection in Hong Kong Proceeding/Conference:Hepatology International | 2015 |